Transcriptional control of the osteocalcin gene by 1,25-dihydroxyvitamin D-2 and its 24-epimer in rat osteosarcoma cells - PubMed (original) (raw)
Comparative Study
. 1995 Aug 22;1263(2):147-53.
doi: 10.1016/0167-4781(95)00091-t.
Affiliations
- PMID: 7640305
- DOI: 10.1016/0167-4781(95)00091-t
Comparative Study
Transcriptional control of the osteocalcin gene by 1,25-dihydroxyvitamin D-2 and its 24-epimer in rat osteosarcoma cells
N C Arbour et al. Biochim Biophys Acta. 1995.
Abstract
The effects of two vitamin D analogs, 1,25-dihydroxyvitamin D-2 and 24-epi-1,25-dihydroxyvitamin D-2, were examined on osteocalcin gene expression in the rat osteosarcoma cell line ROS 17/28. Our results indicate that these analogs are more transcriptionally active than 1,25-dihydroxyvitamin D-3, particularly the 24-epimer. Assessment of reporter gene chloramphenicol acetyltransferase (CAT) activity, using the vitamin D responsive element (VDRE) derived from the human osteocalcin gene promoter. revealed that both analogs stimulated CAT activity 5- to 10-fold. 1,25-Dihydroxyvitamin D-2 was slightly more active than 1,25-dihydroxyvitamin D-3, while the 24-epimer was twice as effective. 1,25-Dihydroxyvitamin D-3 also stimulated osteocalcin mRNA accumulation by 2-fold over vehicle-treated cells, 1,25-dihydroxyvitamin D-2 by 2.5-fold, and 24-epi-1,25-dihydroxyvitamin D-2 by 4-fold. Electrophoretic mobility shift assays using the osteocalcin vitamin D responsive element revealed no increase in DNA binding with either analog when compared to 1,25-(OH)2D3. Examination of CAT activity using the rat 24-hydroxylase VDRE indicated no significant difference in transcription with these compounds, suggesting that the vitamin D-2 analogs preferentially activate osteocalcin gene expression.
Similar articles
- A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
Nanes MS, Kuno H, Demay MB, Kurian M, Hendy GN, DeLuca HF, Titus L, Rubin J. Nanes MS, et al. Endocrinology. 1994 Mar;134(3):1113-20. doi: 10.1210/endo.134.3.8119149. Endocrinology. 1994. PMID: 8119149 - Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H, Kurian SM, Hendy GN, White J, deLuca HF, Evans CO, Nanes MS. Kuno H, et al. Endocrinology. 1994 Jun;134(6):2524-31. doi: 10.1210/endo.134.6.8194478. Endocrinology. 1994. PMID: 8194478 - Synthetic 20-epi analogs of calcitriol are potent inducers of target-gene activation in osteoblastic cells.
Ryhänen S, Mahonen A, Jääskeläinen T, Mäenpää PH. Ryhänen S, et al. Eur J Biochem. 1996 May 15;238(1):97-103. doi: 10.1111/j.1432-1033.1996.0097q.x. Eur J Biochem. 1996. PMID: 8665957 - 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
Baran DT, Sorensen AM, Shalhoub V, Owen T, Oberdorf A, Stein G, Lian J. Baran DT, et al. J Bone Miner Res. 1991 Dec;6(12):1269-75. doi: 10.1002/jbmr.5650061202. J Bone Miner Res. 1991. PMID: 1665280 - Mechanism of action of 1,25-dihydroxyvitamin D on target gene expression.
DeLuca HF, Darwish HM, Ross TK, Moss VE. DeLuca HF, et al. J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:19-26. doi: 10.3177/jnsv.38.special_19. J Nutr Sci Vitaminol (Tokyo). 1992. PMID: 1338439 Review. No abstract available.
Cited by
- Effects of Combined Vitamin K2 and Vitamin D3 Supplementation on Na[18F]F PET/MRI in Patients with Carotid Artery Disease: The INTRICATE Rationale and Trial Design.
Florea A, Kooi ME, Mess W, Schurgers LJ, Bucerius J, Mottaghy FM. Florea A, et al. Nutrients. 2021 Mar 19;13(3):994. doi: 10.3390/nu13030994. Nutrients. 2021. PMID: 33808652 Free PMC article. - Combined low vitamin D and K status amplifies mortality risk: a prospective study.
van Ballegooijen AJ, Beulens JWJ, Kieneker LM, de Borst MH, Gansevoort RT, Kema IP, Schurgers LJ, Vervloet MG, Bakker SJL. van Ballegooijen AJ, et al. Eur J Nutr. 2021 Apr;60(3):1645-1654. doi: 10.1007/s00394-020-02352-8. Epub 2020 Aug 17. Eur J Nutr. 2021. PMID: 32808059 Free PMC article. - Effect of 6-Month Vitamin D Supplementation on Plasma Matrix Gla Protein in Older Adults.
van Ballegooijen AJ, Beulens JWJ, Schurgers LJ, de Koning EJ, Lips P, van Schoor NM, Vervloet MG. van Ballegooijen AJ, et al. Nutrients. 2019 Jan 22;11(2):231. doi: 10.3390/nu11020231. Nutrients. 2019. PMID: 30678199 Free PMC article. Clinical Trial. - Bone Metabolism Markers and Bone Mineral Density in Patients on Long-Term Acenocoumarol Treatment: A Cross-Sectional Study.
Sawicka-Powierza J, Jablonska E, Ratajczak-Wrona W, Rogowska-Szadkowska D, Garley M, Oltarzewska AM, Chlabicz S, Konstantynowicz J. Sawicka-Powierza J, et al. J Clin Med. 2018 Oct 20;7(10):372. doi: 10.3390/jcm7100372. J Clin Med. 2018. PMID: 30347817 Free PMC article. - The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review.
van Ballegooijen AJ, Pilz S, Tomaschitz A, Grübler MR, Verheyen N. van Ballegooijen AJ, et al. Int J Endocrinol. 2017;2017:7454376. doi: 10.1155/2017/7454376. Epub 2017 Sep 12. Int J Endocrinol. 2017. PMID: 29138634 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous